Ypsomed Holding
Ypsomed Holding AG is a Swiss medical technology company specializing in the development and manufacture of injection and infusion systems for self-medication. The company designs and produces pre-filled pens, auto-injectors, pen needles, and automated infusion pumps for diabetes care, fertility treatments, and biopharmaceutical administration. Its operations encompass precision plastic injection molding, automated device assembly, and digital health software integration for patient monitoring. Revenue is derived primarily from supply contracts for medical injection devices sold to global pharmaceutical companies. Ypsomed holds a leading global position in self-injection systems for subcutaneous drug delivery. The company is headquartered in Burgdorf, Switzerland, and its shares trade on the SIX Swiss Exchange.
9 of the funds FundTelligence covers report a position in Ypsomed Holding.
- Legal name
- Ypsomed Holding AG
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 9
- Exposure themes
- Diabetes Technology, Insulin Delivery, Obesity & Metabolic Health
Funds holding Ypsomed Holding
- Schroder ISF European Smaller Companies — Schroders · 2.66 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Smaller Companies — Schroders · 1.17 % (full portfolio disclosed, June 2026)
- Handelsbanken Helse Tema — Handelsbanken · 0.27 % (full portfolio disclosed, October 2026)
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 0.26 % (full portfolio disclosed, September 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.19 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- Nordea Internationale aktier — Nordea Funds · 0.01 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 9 funds holding it.